PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemiaZhaohui Gu, Williams E. Evans, Stanley Pounds et al.|Nature Genetics|2019Cited by 616
The genomic landscape of pediatric acute lymphoblastic leukemiaSamuel W. Brady, Richard C. Harvey, Kathryn G. Roberts et al.|Nature Genetics|2022Cited by 394
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology GroupShalini C. Reshmi, Stephen P. Hunger, Richard C. Harvey et al.|Blood|2017Cited by 305
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemiaZhaohui Gu, Charles G. Mullighan|Nature Communications|2016Cited by 293
OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALLKathryn Evans, Richard B. Lock, Tara Pritchard et al.|Clinical Cancer Research|2019Cited by 53